GlassScriptPhysician profile
James Gasparine
NPI 1093908840
$1,828.55
in general payments reported to CMS, 2019-2025
31 companies · $15.32 in 2025
The $15.32 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.38 · 2020: $11.41 · 2022: $936 · 2023: $520 · 2024: $320 · 2025: $15.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.29 | 2022-2024 | |
| Exact Sciences Corporation | $236.95 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $163.82 | 2019-2023 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $122.63 | 2022-2024 | Farxiga, Breztri |
| Lilly USA, LLC | $110.19 | 2022-2024 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $89.14 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $72.06 | 2022-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Novo Nordisk INC | $69.02 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $53.17 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.97 | 2022 | |
| Fidia Pharma USA INC. | $46.62 | 2019-2024 | Hymovis, Triluron, Hyalgan |
| Ultragenyx Pharmaceutical INC. | $42.98 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $33.04 | 2023 | |
| Antares Pharma, INC. | $32.90 | 2022 | |
| Sanofi Pasteur INC. | $30.19 | 2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28.31 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.51 | 2022 | |
| Ethicon US, LLC | $27.14 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.16 | 2022 | |
| Inspire Medical Systems, INC. | $24.43 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $23.78 | 2022 | |
| Alkermes, INC. | $22.22 | 2024 | Vivitrol |
| Xeris Pharmaceuticals, INC. | $22.04 | 2022 | |
| Abbott Laboratories | $19.12 | 2022 | |
| Dexcom, INC. | $17.99 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $17.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.36 | 2022 | |
| Cdc Medical LLC | $15.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.89 | 2022 | |
| Radius Health, INC. | $14.16 | 2022 | |
| Evoke Pharma, INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gasparine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.